The Ontario Securities Commission (OSC) has issued an order recognizing that Aralez Pharmaceuticals Canada Inc. (the Applicant) has ceased to offer its securities to the public. This decision is based on subsection 1(6) of the Business Corporations Act (Ontario) (OBCA). The Applicant has confirmed that it is an offering corporation under the OBCA and has no plans to seek public financing through securities offerings. Additionally, the Applicant has previously been granted an order confirming it is not a reporting issuer in Ontario or any other Canadian jurisdiction, as per National Policy 11-206. The OSC has determined that granting this order would not be against the public interest. Consequently, as of April 14, 2023, the Applicant is deemed to have ceased public securities offerings.
